img

Global Prostaglandin E2 Receptor EP2 Subtype Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prostaglandin E2 Receptor EP2 Subtype Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Prostaglandin E2 Receptor EP2 Subtype market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, TG-4155 accounting for % of the Prostaglandin E2 Receptor EP2 Subtype global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Clinic segment is altered to an % CAGR throughout this forecast period.
The global key companies of Prostaglandin E2 Receptor EP2 Subtype include Amgen Inc., Ascendis Pharma A/S, Ono Pharmaceutical Co., Ltd., Sanofi and Santen Pharmaceutical Co., Ltd., etc. In 2024, the global top five players had a share approximately % in terms of revenue.
The United States Prostaglandin E2 Receptor EP2 Subtype market size was US$ million in 2024, while China size was US$ million. The proportion of the United States was % in 2024, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Prostaglandin E2 Receptor EP2 Subtype landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Prostaglandin E2 Receptor EP2 Subtype market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Prostaglandin E2 Receptor EP2 Subtype market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Prostaglandin E2 Receptor EP2 Subtype market. Readers of the report can become informed about current and future trends of the global Prostaglandin E2 Receptor EP2 Subtype market and how they will impact market growth during the forecast period.



By Company


Amgen Inc.
Ascendis Pharma A/S
Ono Pharmaceutical Co., Ltd.
Sanofi
Santen Pharmaceutical Co., Ltd.
Segment by Type
TG-4155
SAR-366234
ONO-8055
Treprostinil
Others

Segment by Application


Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Prostaglandin E2 Receptor EP2 Subtype in global and regional level.
Chapter 3Detailed analysis of Prostaglandin E2 Receptor EP2 Subtype companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostaglandin E2 Receptor EP2 Subtype revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 TG-4155
1.2.3 SAR-366234
1.2.4 ONO-8055
1.2.5 Treprostinil
1.2.6 Others
1.3 Market by Application
1.3.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Size (2018-2034)
2.2 Prostaglandin E2 Receptor EP2 Subtype Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Region (2018-2023)
2.4 Global Prostaglandin E2 Receptor EP2 Subtype Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Prostaglandin E2 Receptor EP2 Subtype Countries Ranking by Market Size
3 Prostaglandin E2 Receptor EP2 Subtype Competitive by Company
3.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Players
3.1.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Players (2018-2023)
3.1.2 Global Prostaglandin E2 Receptor EP2 Subtype Market Share by Players (2018-2023)
3.2 Global Prostaglandin E2 Receptor EP2 Subtype Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Prostaglandin E2 Receptor EP2 Subtype Revenue
3.4 Global Prostaglandin E2 Receptor EP2 Subtype Market Concentration Ratio
3.4.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostaglandin E2 Receptor EP2 Subtype Revenue in 2024
3.5 Global Key Players of Prostaglandin E2 Receptor EP2 Subtype Head office and Area Served
3.6 Global Key Players of Prostaglandin E2 Receptor EP2 Subtype, Product and Application
3.7 Global Key Players of Prostaglandin E2 Receptor EP2 Subtype, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Prostaglandin E2 Receptor EP2 Subtype Breakdown Data by Type
4.1 Global Prostaglandin E2 Receptor EP2 Subtype Historic Revenue by Type (2018-2023)
4.2 Global Prostaglandin E2 Receptor EP2 Subtype Forecasted Revenue by Type (2024-2034)
5 Global Prostaglandin E2 Receptor EP2 Subtype Breakdown Data by Application
5.1 Global Prostaglandin E2 Receptor EP2 Subtype Historic Market Size by Application (2018-2023)
5.2 Global Prostaglandin E2 Receptor EP2 Subtype Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2023)
6.2 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2018-2034)
6.3 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2018-2034)
6.4 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2023)
7.2 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2018-2034)
7.3 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2018-2034)
7.4 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2023)
8.2 Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2018-2034)
8.3 Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2018-2034)
8.4 Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2023)
9.2 Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2018-2034)
9.3 Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2018-2034)
9.4 Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2023)
10.2 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2018-2034)
10.3 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2018-2034)
10.4 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Products and Services
11.1.4 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Revenue in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023)
11.1.5 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype SWOT Analysis
11.1.6 Amgen Inc. Recent Development
11.2 Ascendis Pharma A/S
11.2.1 Ascendis Pharma A/S Company Details
11.2.2 Ascendis Pharma A/S Business Overview
11.2.3 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Products and Services
11.2.4 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Revenue in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023)
11.2.5 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype SWOT Analysis
11.2.6 Ascendis Pharma A/S Recent Development
11.3 Ono Pharmaceutical Co., Ltd.
11.3.1 Ono Pharmaceutical Co., Ltd. Company Details
11.3.2 Ono Pharmaceutical Co., Ltd. Business Overview
11.3.3 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Products and Services
11.3.4 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023)
11.3.5 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype SWOT Analysis
11.3.6 Ono Pharmaceutical Co., Ltd. Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Prostaglandin E2 Receptor EP2 Subtype Products and Services
11.4.4 Sanofi Prostaglandin E2 Receptor EP2 Subtype Revenue in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023)
11.4.5 Sanofi Prostaglandin E2 Receptor EP2 Subtype SWOT Analysis
11.4.6 Sanofi Recent Development
11.5 Santen Pharmaceutical Co., Ltd.
11.5.1 Santen Pharmaceutical Co., Ltd. Company Details
11.5.2 Santen Pharmaceutical Co., Ltd. Business Overview
11.5.3 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Products and Services
11.5.4 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023)
11.5.5 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype SWOT Analysis
11.5.6 Santen Pharmaceutical Co., Ltd. Recent Development
12 Prostaglandin E2 Receptor EP2 Subtype Market Dynamics
12.1 Prostaglandin E2 Receptor EP2 Subtype Industry Trends
12.2 Prostaglandin E2 Receptor EP2 Subtype Market Drivers
12.3 Prostaglandin E2 Receptor EP2 Subtype Market Challenges
12.4 Prostaglandin E2 Receptor EP2 Subtype Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Prostaglandin E2 Receptor EP2 Subtype Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of TG-4155
Table 3. Key Players of SAR-366234
Table 4. Key Players of ONO-8055
Table 5. Key Players of Treprostinil
Table 6. Key Players of Others
Table 7. Global Prostaglandin E2 Receptor EP2 Subtype Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 8. Global Prostaglandin E2 Receptor EP2 Subtype Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 9. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 11. Global Prostaglandin E2 Receptor EP2 Subtype Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 12. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Players (2018-2023) & (US$ Million)
Table 13. Global Prostaglandin E2 Receptor EP2 Subtype Market Share by Players (2018-2023)
Table 14. Global Top Prostaglandin E2 Receptor EP2 Subtype Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostaglandin E2 Receptor EP2 Subtype as of 2024)
Table 15. Ranking of Global Top Prostaglandin E2 Receptor EP2 Subtype Companies by Revenue (US$ Million) in 2024
Table 16. Global 5 Largest Players Market Share by Prostaglandin E2 Receptor EP2 Subtype Revenue (CR5 and HHI) & (2018-2023)
Table 17. Global Key Players of Prostaglandin E2 Receptor EP2 Subtype, Headquarters and Area Served
Table 18. Global Key Players of Prostaglandin E2 Receptor EP2 Subtype, Product and Application
Table 19. Global Key Players of Prostaglandin E2 Receptor EP2 Subtype, Date of Enter into This Industry
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Type (2018-2023) & (US$ Million)
Table 22. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2018-2023)
Table 23. Global Prostaglandin E2 Receptor EP2 Subtype Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 24. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2024-2034)
Table 25. Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Application (2018-2023) & (US$ Million)
Table 26. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2018-2023)
Table 27. Global Prostaglandin E2 Receptor EP2 Subtype Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 28. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2024-2034)
Table 29. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2023) & (US$ Million)
Table 30. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2018-2023) & (US$ Million)
Table 31. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2024-2034) & (US$ Million)
Table 32. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2018-2023) & (US$ Million)
Table 33. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2024-2034) & (US$ Million)
Table 34. North America Prostaglandin E2 Receptor EP2 Subtype Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2018-2023) & (US$ Million)
Table 36. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2024-2034) & (US$ Million)
Table 37. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2023) & (US$ Million)
Table 38. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2018-2023) & (US$ Million)
Table 39. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2024-2034) & (US$ Million)
Table 40. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2018-2023) & (US$ Million)
Table 41. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2024-2034) & (US$ Million)
Table 42. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2018-2023) & (US$ Million)
Table 44. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2024-2034) & (US$ Million)
Table 45. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2023) & (US$ Million)
Table 46. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2018-2023) & (US$ Million)
Table 47. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2024-2034) & (US$ Million)
Table 48. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2018-2023) & (US$ Million)
Table 49. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2024-2034) & (US$ Million)
Table 50. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 51. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2018-2023) & (US$ Million)
Table 52. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2024-2034) & (US$ Million)
Table 53. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2023) & (US$ Million)
Table 54. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2018-2023) & (US$ Million)
Table 55. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2024-2034) & (US$ Million)
Table 56. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2018-2023) & (US$ Million)
Table 57. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2024-2034) & (US$ Million)
Table 58. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 59. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2018-2023) & (US$ Million)
Table 60. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2024-2034) & (US$ Million)
Table 61. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Company (2021-2023) & (US$ Million)
Table 62. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2018-2023) & (US$ Million)
Table 63. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2024-2034) & (US$ Million)
Table 64. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2024-2034) & (US$ Million)
Table 66. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 67. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2018-2023) & (US$ Million)
Table 68. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2024-2034) & (US$ Million)
Table 69. Amgen Inc. Company Details
Table 70. Amgen Inc. Business Overview
Table 71. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Product and Services
Table 72. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Revenue in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023) & (US$ Million)
Table 73. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype SWOT Analysis
Table 74. Amgen Inc. Recent Development
Table 75. Ascendis Pharma A/S Company Details
Table 76. Ascendis Pharma A/S Business Overview
Table 77. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Product and Services
Table 78. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Revenue in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023) & (US$ Million)
Table 79. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype SWOT Analysis
Table 80. Ascendis Pharma A/S Recent Development
Table 81. Ono Pharmaceutical Co., Ltd. Company Details
Table 82. Ono Pharmaceutical Co., Ltd. Business Overview
Table 83. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product and Services
Table 84. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023) & (US$ Million)
Table 85. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype SWOT Analysis
Table 86. Ono Pharmaceutical Co., Ltd. Recent Development
Table 87. Sanofi Company Details
Table 88. Sanofi Business Overview
Table 89. Sanofi Prostaglandin E2 Receptor EP2 Subtype Product and Services
Table 90. Sanofi Prostaglandin E2 Receptor EP2 Subtype Revenue in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023) & (US$ Million)
Table 91. Sanofi Prostaglandin E2 Receptor EP2 Subtype SWOT Analysis
Table 92. Sanofi Recent Development
Table 93. Santen Pharmaceutical Co., Ltd. Company Details
Table 94. Santen Pharmaceutical Co., Ltd. Business Overview
Table 95. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product and Services
Table 96. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023) & (US$ Million)
Table 97. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype SWOT Analysis
Table 98. Santen Pharmaceutical Co., Ltd. Recent Development
Table 99. Prostaglandin E2 Receptor EP2 Subtype Market Trends
Table 100. Prostaglandin E2 Receptor EP2 Subtype Market Drivers
Table 101. Prostaglandin E2 Receptor EP2 Subtype Market Challenges
Table 102. Prostaglandin E2 Receptor EP2 Subtype Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostaglandin E2 Receptor EP2 Subtype Product Picture
Figure 2. Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global Prostaglandin E2 Receptor EP2 Subtype Market Share by Type: 2024 VS 2034
Figure 4. TG-4155 Features
Figure 5. SAR-366234 Features
Figure 6. ONO-8055 Features
Figure 7. Treprostinil Features
Figure 8. Others Features
Figure 9. Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 10. Global Prostaglandin E2 Receptor EP2 Subtype Market Share by Application: 2024 VS 2034
Figure 11. Clinic
Figure 12. Hospital
Figure 13. Others
Figure 14. Prostaglandin E2 Receptor EP2 Subtype Report Years Considered
Figure 15. Global Prostaglandin E2 Receptor EP2 Subtype Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Prostaglandin E2 Receptor EP2 Subtype Market Size 2018-2034 (US$ Million)
Figure 17. Global Prostaglandin E2 Receptor EP2 Subtype Market Size Market Share by Region: 2024 VS 2034
Figure 18. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Region in 2018 VS 2024
Figure 19. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share Forecast by Region (2024-2034)
Figure 20. Global Top 10 Prostaglandin E2 Receptor EP2 Subtype Countries Ranking by Market Size (US$ Million) in 2024
Figure 21. Global Prostaglandin E2 Receptor EP2 Subtype Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 22. Global Prostaglandin E2 Receptor EP2 Subtype Market Share by Players in 2024
Figure 23. Global Top Prostaglandin E2 Receptor EP2 Subtype Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostaglandin E2 Receptor EP2 Subtype as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Prostaglandin E2 Receptor EP2 Subtype Revenue in 2024
Figure 25. North America Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Company in 2024
Figure 26. North America Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2018-2034)
Figure 27. North America Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2018-2034)
Figure 28. North America Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Country (2018-2034)
Figure 29. U.S. Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 30. Canada Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 31. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Company in 2024
Figure 32. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2018-2034)
Figure 33. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2018-2034)
Figure 34. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Country (2018-2034)
Figure 35. Germany Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 36. France Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 37. U.K. Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 38. Italy Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 39. Russia Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 40. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Company in 2024
Figure 41. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2018-2034)
Figure 42. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2018-2034)
Figure 43. Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Region (2018-2034)
Figure 44. China Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 45. Japan Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 46. South Korea Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 47. India Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 48. Australia Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 49. Taiwan Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 50. Indonesia Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 51. Thailand Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 52. Malaysia Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 53. Philippines Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 54. Vietnam Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 55. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Company in 2024
Figure 56. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2018-2034)
Figure 57. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2018-2034)
Figure 58. Latin America Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Country (2018-2034)
Figure 59. Mexico Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 60. Brazil Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 61. Argentina Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 62. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Company in 2024
Figure 63. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type (2018-2034)
Figure 64. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2018-2034)
Figure 65. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Country (2018-2034)
Figure 66. Turkey Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 67. Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 68. UAE Prostaglandin E2 Receptor EP2 Subtype Revenue (2018-2034) & (US$ Million)
Figure 69. Amgen Inc. Revenue Growth Rate in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023)
Figure 70. Ascendis Pharma A/S Revenue Growth Rate in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023)
Figure 71. Ono Pharmaceutical Co., Ltd. Revenue Growth Rate in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023)
Figure 72. Sanofi Revenue Growth Rate in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023)
Figure 73. Santen Pharmaceutical Co., Ltd. Revenue Growth Rate in Prostaglandin E2 Receptor EP2 Subtype Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed